Kazakhstan vs Lesotho: Access to anti-retroviral drugs, male
Kazakhstan
88.0%
in 2024
Lesotho
88.0%
in 2024
Kazakhstan rank
23rd
Lesotho rank
23rd
Access to anti-retroviral drugs, male over time
- Kazakhstan
- Lesotho
How they compare
Kazakhstan currently reports 88.0% against 88.0% in Lesotho, a difference of 0.0%.
Across all 25 years both countries report, Lesotho has been ahead every year.
Kazakhstan ranks 23rd and Lesotho ranks 23rd of 141 countries.
Lesotho has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Lesotho | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.1% | 7.3% | 5.2% | Lesotho |
| 2010s | 27.7% | 47.6% | 19.9% | Lesotho |
| 2020s | 76.0% | 82.2% | 6.2% | Lesotho |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Kazakhstan or Lesotho?
- Kazakhstan, at 88.0% against 88.0% in Lesotho as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Kazakhstan and Lesotho?
- 0.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Lesotho?
- 25 years are reported by both, from 2000 to 2024.
- How do Kazakhstan and Lesotho rank globally for access to anti-retroviral drugs, male?
- Kazakhstan ranks 23rd and Lesotho ranks 23rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.